Scientists have taken a major step toward developing an effective HIV vaccine after a new experimental vaccine successfully ...

Researchers said an effective HIV vaccine would need to stimulate the immune system to produce neutralising antibodies.

Antiretroviral therapy has decreased the risk of lymphoma in the HIV-positive patient population, yet the incidence is still approximately 70-times greater than the incidence in the noninfected ...

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...

The human immunodeficiency virus HIV-1 belongs to the family of lentiviruses, which poses special challenges to medicine. HIV causes AIDS, a slowly progressing, chronic infectious disease, by ...

For decades scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years of probing work and extensive experimentation, a Yale research team has ...

An experimental HIV vaccine candidate developed by LJI, Scripps Research and IAVI generated high levels of broadly ...

Highlights:Scientists at La Jolla Institute for Immunology and Scripps Research have developed an HIV vaccine that trains immune cells to see past ...

The fifth UN High-Level Meeting on HIV/AIDS (June 22–23) saw the agreement of a new Political Declaration on HIV/AIDS. In it, countries expressed commitments to end AIDS as a public health threat by ...

HIV is the virus that causes AIDS. The illness known as HIV/AIDS happens in three stages: acute HIV infection, chronic HIV infection, and AIDS. But the phrase “chronic HIV infection” isn’t simply the ...